July 31 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS AND FIVEPHUSION ANNOUNCE
COLLABORATION TO
SUPPORT CLINICAL DEVELOPMENT OF DEFLEXIFOL™ WITH DRP® COMPANION
DIAGNOSTICS
* ALLARITY THERAPEUTICS INC - WILL SUPPORT FIVEPHUSION'S
FUTURE
CLINICAL DEVELOPMENT OF DEFLEXIFOL(™) FOR TREATMENT OF SOLID
TUMORS
* ALLARITY THERAPEUTICS INC - FINANCIAL TERMS OF CLINICAL
COLLABORATION, OPTION AND POTENTIAL LICENSE ARE NOT DISCLOSED
* ALLARITY THERAPEUTICS INC - TO RECEIVE CERTAIN MILESTONE
PAYMENTS TRIGGERED BY REGULATORY APPROVALS OF DEFLEXIFOL,
ATTAINMENT OF DRUG SALES BENCHMARKS
Source text for Eikon: ID:nGNX9TG4K1
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))